Skip to main content

Table 2 Key multiple sclerosis (MS) registry studies in Europe, North America and globally

From: The importance of collecting structured clinical information on multiple sclerosis

Registry

Patients, n

Europe

 Croatia (SDMSH)

2477

 Denmark (DMSC)

12,500

 France (EDMUS)

~40,000

 Germany (DMSG)

~30,000

 Germany (MSDS3D Users)

>5000

 Greece (GMSS)

3500

 Italy (iMed/web)

~20,000

 Norway (Nasjonal kompetansetjeneste for multippel sklerose – MS)

5100

 Russia

21,500

 Serbia

3500

 Spain (Catalonia; EpidEMcat)

>5000

 Sweden (SMSreg)

12,900

 Switzerland (SMSR)

270

 United Kingdom (MS Register)

8300

North America

 Canada (London Ontario)

1099

 Canada (British Columbia)

2837

 USA (New York; NYSMSC)

9600a

 USA (NARCOMS)

19,297

Global

 MSBase (31 countries)

39,030

  1. Patient numbers are derived from the original publications [30, 44] and may have changed
  2. aNumbers updated by NYSMSC, 6 May 2016
  3. DMSC, Danish Multiple Sclerosis Center; DMSG, National Multiple Sclerosis Society of Germany; EDMUS, European Database for Multiple Sclerosis; EpidEMcat, Catalonia MS Registry; GMSS, Greek Multiple Sclerosis Society; NARCOMS, North American Research Committee on Multiple Sclerosis; NYSMSC, New York State Multiple Sclerosis Consortium; MSBase, Multiple Sclerosis database; SDMSH, Croatian Multiple Sclerosis Society; SMSR, Scottish Multiple Sclerosis Register; SMSreg, Swedish MS registry